<DOC>
	<DOC>NCT00474539</DOC>
	<brief_summary>The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomitantly with routine paediatric vaccinations in Spain.</brief_summary>
	<brief_title>Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2monthold infants Available for the entire study period Exclusion criteria: Previous vaccination with any vaccine before the start of the study Known contraindication to vaccination</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Vaccine</keyword>
</DOC>